ABAtle Bjørnerud

Atle Bjørnerud

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Atle Bjørnerud has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Fast Method for Whole Liver- and Colorectal Liver Metastasis Segmentations from MRI Using 3D FCNN Networks

    by Yuliia Kamkova, Egidijus Pelanis, Atle Bjørnerud, Bjørn Edwin, Ole Jakob Elle, Rahul Prasanna Kumar

    The liver is the most frequent organ for metastasis from colorectal cancer, one of the most common tumor types with a poor prognosis. Despite reducing surgical planning time and providing better spatial representation, current methods of 3D modeling of patient-specific liver anatomy are extremely time-consuming. The purpose of this study was to develop a deep learning model trained on an in-house dataset of 84 MRI volumes to rapidly provide fully automated whole liver and liver lesions segmentation from volumetric MRI series. A cascade approach was utilized to address the problem of class imbalance. The trained model achieved an average Dice score for whole liver segmentation of 0.944 ± 0.009 and 0.780 ± 0.119 for liver lesion segmentation. Furthermore, applying this method to a not-annotated dataset creates a complete 3D segmentation in less than 6 s per MRI volume, with a mean segmentation Dice score of 0.994 ± 0.003 for the liver and 0.709 ± 0.171 for tumors compared to manual corrections applied after the inference was achieved. Availability and integration of our method in clinical practice may improve diagnosis and treatment planning in patients with colorectal liver metastasis and open new possibilities for research into liver tumors.


  • Open Access

    Quantification of Tissue Compression Identifies High-Grade Glioma Patients with Reduced Survival

    by Elies Fuster-Garcia, Ivar Thokle Hovden, Siri Fløgstad Svensson, Christopher Larsson, Jonas Vardal, Atle Bjørnerud, Kyrre E. Emblem

    The compression of peritumoral healthy tissue in brain tumor patients is considered a major cause of the life-threatening neurologic symptoms. Although significant deformations caused by the tumor growth can be observed radiologically, the quantification of minor tissue deformations have not been widely investigated. In this study, we propose a method to quantify subtle peritumoral deformations. A total of 127 MRI longitudinal studies from 23 patients with high-grade glioma were included. We estimate longitudinal displacement fields based on a symmetric normalization algorithm and we propose four biomarkers. We assess the interpatient and intrapatient association between proposed biomarkers and the survival based on Cox analyses, and the potential of the biomarkers to stratify patients according to their survival based on Kaplan–Meier analysis. Biomarkers show a significant intrapatient association with survival (p < 0.05); however, only compression biomarkers show the ability to stratify patients between those with higher and lower overall survival (AUC = 0.83, HR = 6.30, p < 0.05 for CompCH). The compression biomarkers present three times higher Hazard Ratios than those representing only displacement. Our study provides a robust and automated method for quantifying and delineating compression in the peritumoral area. Based on the proposed methodology, we found an association between lower compression in the peritumoral area and good prognosis in high-grade glial tumors.


  • Open Access

    Waves of Maturation and Senescence in Micro-Structural MRI Markers of Human Cortical Myelination over the Lifespan

    by Håkon Grydeland, Petra E. Vértes, František Váša, Rafael Romero-Garcia, Kirstie J. Whitaker, Aaron Felix Alexander-Bloch, Atle Bjørnerud, Ameera X. Patel, Donatas Sedervicius, Christian K. Tamnes, et al.

    Seminal human brain histology work has demonstrated developmental waves of myelination. Here, using a micro-structural magnetic resonance imaging (MRI) marker linked to myelin, we studied fine-grained age differences to deduce waves of growth, stability, and decline of cortical myelination over the life-cycle. In 484 participants, aged 8-85 years, we fitted smooth growth curves to T1- to T2-weighted ratio in each of 360 regions from one of 7 cytoarchitectonic classes. From the first derivatives of these generally inverted-U trajectories, we defined three milestones: the age at peak growth; the age at onset of a stable plateau; and the age at the onset of decline. Age at peak growth had a bimodal distribution comprising an early (pre-pubertal) wave of primary sensory and motor cortices and a later (post-pubertal) wave of association, insular and limbic cortices. Most regions reached stability in the 30s but there was a second wave reaching stability in the 50s. Age at onset of decline was also bimodal: in some right hemisphere regions, the curve declined from the 60s, but in other left hemisphere regions, there was no significant decline from the stable plateau. These results are consistent with regionally heterogeneous waves of intracortical myelinogenesis and age-related demyelination.

  • Open Access

    Signal Enhancement of the Dentate Nucleus at Unenhanced MR Imaging after Very High Cumulative Doses of the Macrocyclic Gadolinium-based Contrast Agent Gadobutrol: An Observational Study

    by Atle Bjørnerud, Svein Are Sirirud Vatnehol, Christopher Larsson, Paulina Due-Tønnessen, Per Kristian Hol, Inge Rasmus Groote

    The authors of this study measured a significantly increased and dose-dependent normalized signal intensity on unenhanced T1-weighted gradient-echo images in the dentate nucleus after multiple administrations of the macrocyclic gadolinium-based contrast agent gadobutrol. Purpose To test for measurable visual enhancement of the dentate nucleus (DN) on unenhanced T1-weighted magnetic resonance (MR) images in a cohort of patients with a primary brain tumor who had not received linear gadolinium-based contrast agents (GBCAs) but had received many injections of macrocyclic GBCAs. Materials and Methods Seventeen patients with high-grade gliomas who had received 10–44 administrations of the macrocyclic GBCA gadobutrol (0.1 mmol/kg of body weight) were retrospectively included in this regional ethics committee–approved study. Two neuroradiologists inspected T1-weighted MR images with optimized window settings to visualize small differences in contrast at the baseline and at the last examination for the presence of visual DN signal enhancement. Signal intensity (SI) in the DN was normalized to the SI of the pons, and a one-sample t test was used to test for differences between baseline normalized SI (nSI) in the DN (nSIDN) and the average change in nSIDN of all postbaseline MR ima...


  • Reduced perfusion in white matter lesions in multiple sclerosis

    by Piotr Sowa, Atle Bjørnerud, Gro O. Nygaard, Soheil Damangir, Gabriela Spulber, Elisabeth G. Celius, Paulina Due-Tønnessen, Hanne F. Harbo, Mona K. Beyer


  • Open Access

    T1in high-grade glioma and the influence of different measurement strategies on parameter estimations in DCE-MRI

    by Christopher Larsson, Magne Kleppestø, Inge Grothe, Jonas Vardal, Atle Bjørnerud


  • Open Access

    T1- and T*2-Dominant Extravasation Correction in DSC-MRI: Part I—Theoretical Considerations and Implications for Assessment of Tumor Hemodynamic Properties

    by Atle Bjornerud, A Gregory Sorensen, Kim Mouridsen, Kyrre E Emblem

    We present a novel contrast agent (CA) extravasation-correction method based on analysis of the tissue residue function for assessment of multiple hemodynamic parameters. The method enables semiquantitative determination of the transfer constant and can be used to distinguish between T1- and T*2-dominant extravasation effects, while being insensitive to variations in tissue mean transit time (MTT). Results in 101 patients with confirmed glioma suggest that leakage-corrected absolute cerebral blood volume (CBV) values obtained with the proposed method provide improved overall survival prediction compared with normalized CBV values combined with an established leakage-correction method. Using a standard gradient-echo echo-planar imaging sequence, ∼60% and 10% of tumors with detectable CA extravasation mainly exhibited T1- and T*2-dominant leakage effects, respectively. The remaining 30% of leaky tumors had mixed T1- and T*2-dominant effects. Using an MTT-sensitive correction method, our results show that CBV is underestimated when tumor MTT is significantly longer than MTT in the reference tissue. Furthermore, results from our simulations suggest that the relative contribution of T1-versus T*2-dominant extravasation effects is strongly dependent on the effective transverse relaxivity in the extravascular space and may thus be a potential marker for cellular integrity and tissue structure.